Mrs. Janice Lee Fritsche, OTRL Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1500 E 15th St, Rm306, Douglas, AZ 85607 Phone: 520-364-2447 |
News Archive
Researchers worldwide are seeking to define ancient sections of our genetic code that may soon be as important to medical science as genes.
Next milestone in the development of bionic arm prostheses with major contribution from the Medical University of Vienna: in collaboration with the Massachusetts Institute of Technology (Center for Extreme Bionics) and the Department of Electrical Engineering at the University of Gothenburg, Oskar Aszmann's team in the Clinical Laboratory for Bionic Limb Reconstruction at MedUni Vienna's Department of Surgery has developed the world's first fully integrated bionic arm prosthesis that is ready to use - in keeping with the motto "Plug and Play".
A new study by Dr. Anat Gesser-Edelsburg, Dr. Yaffa Shir-Raz and Prof. Manfred S. Green from University of Haifa, School of Public Health, published in the Journal of Risk Research suggests that even parents who are not "vaccine refusers" and who usually comply with the routine vaccination programs may hesitate or refuse to vaccinate their children based on poor communication from the relevant healthcare provider, as well as concerns about the safety of the vaccine.
Better designed vaccines for insect-spread viruses like dengue and Zika are likely after researchers discovered models of immature flavivirus particles were originally misinterpreted.
Synthetech, Inc. today announced financial results for the first quarter of fiscal 2011, which ended June 30, 2010. Revenue for the quarter was $2.0 million, a 56% decrease compared to revenue of $4.7 million in the first quarter of fiscal 2010. The operating loss for the current quarter was $727,000, compared to operating income of $1.0 million for the same period last year. The net loss for the current quarter was $763,000, or $0.05 per basic share, compared to last year's first quarter net income of $969,000, or $0.07 per basic share.
› Verified 2 days ago